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The easy and wide availability of brain mag-
netic resonance imaging (MRI) in the past 
two decades has led to its increasing use in 
evaluation of a variety of neurological symp-
toms.  Given its widespread use, it is com-
mon to detect some incidental findings in 
patients undergoing brain MRI for unrelated 
medical indications, such as head trauma or 
headache.  The most common of these inci-
dental abnormalities are white matter lesions 
that based on their appearance, location, and 
distribution are consistent with demye-
lination or multiple sclerosis (MS) but are 
not associated with any clinical symptoms 
suggestive of MS.  The term radiologically 
isolated syndrome (RIS) has been proposed  
 
 
to describe this entity.    
 
Coined only recently, RIS was first used by 
Okuda et al1 to describe subjects with no ob-
vious present or past neurological symptoms 
suggestive of MS, normal neurological ex-
amination, and white matter lesions on brain 
MRI fulfilling the radiological criteria of 
MS.2  The proposed criteria for RIS are listed 
in Table 1.  The Barkhof criteria for radio-
logical evidence of dissemination are depict-
ed in Table 2. 
 
Before the advent and wider availability of 
MRI, postmortem studies showed a low 






The use of brain magnetic resonance imaging (MRI) for evaluation of 
neurological disorders has increased in the past two decades.  This 
has led to an increased detection of incidental findings on brain MRI. 
The most common of these asymptomatic abnormalities are white 
matter lesions that are interpreted as demyelinating based on radiolog-
ical criteria.  However, in the absence of associated clinical symptoms 
suggestive of multiple sclerosis (MS), a definite diagnosis of MS can-
not be made in patients with these incidental white matter lesions. 
These patients are now diagnosed as radiologically isolated syndrome 
(RIS).  The natural history and clinical approach to patients with RIS 
are reviewed in this article.  
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linating disease.3, 4  The recent studies in-
cluding MR imaging have shown somewhat 
higher prevalence of white matter lesions 
suggestive of demyelination in asymptomatic 
individuals, especially among asymptomatic 
family members of patients with MS.  In a 
recent study using 3 T MR imaging, about 
3% of healthy relatives of MS patients and 
2.4% of non-familial healthy control subjects 
showed white matter lesions suggestive of 
demyelination according to Barkhof criteria.5 
In another study, the prevalence of white  
 
matter lesions was 7% in asymptomatic first 
degree relatives of MS patients using Bar-
khof and other MRI diagnostic criteria for 
MS.6  
 
The clinical significance and prognostic im-
plication of subclinical lesions in patients 
with RIS remains controversial.  There is 
some evidence to suggest that the patients 
with RIS are at increased risk of developing 
MS over time with approximately two thirds 
showing radiological progression and one 
Table 1: Proposed diagnostic criteria for radiologically isolated syndrome1  
 
A.  The presence of incidentally identified CNS white matter anomalies meeting the following MRI criteria: 
1.  Ovoid, well-circumscribed, and homogeneous foci observed with or without involvement of the 
corpus callosum 
2.  T2 hyperintensities measuring ≥3 mm and fulfilling Barkhof criteria (at least three out of four) for 
dissemination in space 
3.  Anomalies not following a clear vascular pattern 
4.  Structural neuroimaging abnormalities identified not explained by another disease process 
B.  No historical accounts of remitting clinical symptoms consistent with neurological dysfunction 
C.  The MRI anomalies do not account for clinically apparent impairments in social, occupational, or gener-
alized area of functioning 
D.  The MRI anomalies are not due to the direct physiological effects of substances (recreational drug use, 
toxic exposure) or a medical condition 
E.  Exclusion of individuals with MRI phenotypes suggestive of leukoaraiosis or extensive white matter 
changes lacking clear involvement of the corpus callosum 
F.  The CNS MRI anomalies are not better accounted for by another disease process 
Table 2: Barkhof’s proposed MRI criteria for MS 2  
 
T2 lesions ≥9 T2 hyperintense or ≥1 
gadolinium enhancing 
Infratentorial lesions ≥1 
Juxtacortical lesions ≥1 
Periventricular lesions ≥4 
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third developing clinical symptoms in five 
years.7  In a study of 44 patients diagnosed 
with RIS and followed longitudinally, more 
than half (24 of 41) showed radiological pro-
gression within an average of 2.7 years and 
30% (10 of 30) went on to develop clinical 
symptoms leading to the diagnosis of clini-
cally isolated syndrome (CIS) or clinically 
definite MS (CDMS).1  The average time be-
tween RIS diagnosis and progression to CIS 
was 5.4 years, ranging from 1.1 – 9.8 years. 
The predictors of clinical or radiological pro-
gression included higher T2 lesion load, 
presence of infratentorial or spinal cord le-
sions, and positive cerebrospinal fluid (CSF) 
oligoclonal bands.8  Lebrun et al. found a 
similar rate of conversion to CIS in their 
study of 70 patients with RIS; 33% devel-
oped clinical symptoms within an average of 
2.3 years.9  In this study, visual evoked po-
tential abnormalities, young age, and gado-
linium enhancement were more frequently 
found in patients who progressed to clinical-
ly definite MS whereas gadolinium enhance-
ment and infratentorial lesions were associat-
ed with increased likelihood of MRI conver-
sion.  Presence of CSF oligoclonal bands or 
increased IgG index with a high T2-
hyperintense lesion load at presentation was 
predictive of conversion to CIS.  These find-
ings are similar to the published data in CIS, 
where presence of oligoclonal IgG bands 
plus two T2-hyperintense lesions predicts 
CIS conversion to MS10.  In another study, 
the strongest predictor of clinical progression 
was the presence of cervical cord lesions; 21 
of 25 (84%) RIS patients with cervical cord 
lesions on MRI went on to develop clinical 
symptoms over a median period of 1.6 
years.8   
 
Thus, factors including the presence of cervi-
cal cord lesions, CSF abnormalities, and 
higher baseline T2 lesion load may help rec-
ognize patients who may be at relatively 
higher risk of MS and may benefit from a 
closer surveillance.  It has been proposed that 
the patients with RIS be stratified into low or 
high risk groups for future development of 
MS based on these clinical or radiological 
predictors.  It must be taken into considera-
tion that most of these studies of RIS have 
included relatively small numbers of patients 
with variable periods of follow-up, and larger 
longitudinal studies need to be done to fur-
ther validate these proposed risk factors.   
 
What are the clinical implications of current-
ly available data?  These data suggest that 
RIS may be a precursor to MS; however, RIS 
probably represents a somewhat heterogene-
ous group.  Some of these patients probably 
have a relatively mild and benign form of 
MS with symptoms so minor that they are 
not detectable clinically and may never pro-
gress; whereas other patients who present in 
the preclinical or presymptomatic phase of 
MS will later develop symptoms and/or new 
MRI lesions.  Of the latter, there may be a 
subgroup of individuals who may be at a rel-
atively higher risk of developing MS if they 
possess one or more risk factors such as fam-
ily history of MS, higher baseline T2 lesion 
load, presence of cervical cord lesion, and 
CSF oligoclonal bands.  The other issue re-
lates to the treatment recommendations for 
patients with RIS.  Although some might 
support use of disease modifying therapy 
(DMT) in these patients to delay the clinical 
or radiological progression similar to CIS 
patients, there are no studies to suggest this 
might be beneficial even for RIS patients at 
higher risk of MS.  Moreover, the risk factors 
are not always clear, and the other caveat 
may be misdiagnosis of RIS in some cases 
where other conditions may mimic MS radi-
ologically.11,12  Given the uncertainty about 
the diagnosis and management of these pa-
tients, only a small proportion of RIS pa-
tients get treated with disease modifying 
therapy.7   
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There is currently no set protocol for manag-
ing patients with RIS.  These patients are 
usually followed with surveillance MRIs 
every six months to a year or on as needed 
basis depending on the patient’s wishes and 
the treating neurologist's preference.13  If 
clinical symptoms develop over time 
(conversion to CIS), most of these patients 
would be initiated on DMT.  There is, how-
ever, a lack of evidence to support the use of 
DMT in RIS patients who show radiological 
progression on follow up imaging in absence 
of clinical progression. 
 
As apparent from the discussion above, there 
are many questions that remain to be an-
swered.  Are there any biological or other 
markers that can help identify RIS patients 
who do or do not progress?  For those who 
do convert to CIS or CDMS, would early 
treatment with DMT in the RIS stage have 
prevented the conversion?  Future random-
ized prospective clinical trials may not only 
help answer the question whether early initi-
ation of DMT in RIS patients would prevent 
conversion to CIS or radiological progression 
but may also further validate the risk factors 
for conversion.  With such limited 
knowledge of the pathologic significance be-
hind RIS, its relationship to MS, and how 
treatment or lack thereof affects the long 
term prognosis, the clinical management of 
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